Full of Articles - Health and Fitness

A new era for rheumatoid arthritis is beginning to unfold, leading the charge is several

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

new drugs which are giving arthritis sufferers new options that many have never enjoyed

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

A new study released Tuesday, three new drugs; rituximab, abatacept and tocilizumab ar

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

on the cutting edge of science. Rheumatoid arthritis is a chronic inflammatory joint di

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ease that attacks the joints, producing harsh pain, stiffness and swelling. Rituximab an

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

abatacept have already received approval to treat of patients who suffer from this pain

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ul illness. Tocilizumab is still in phase III clinical trials testing.

According to Hea

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

thDay, Traditional treatments for rheumatoid arthritis include nonsteroidal anti-inflamm

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

tory drugs (NSAIDs), glucocorticoids, and disease-modifying anti-rheumatic drugs (DMARDs

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

, which include the widely used Methotrexate. But only DMARDs, and to a certain extent g

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ucocorticoids, can slow or halt rheumatoid arthritis' inflammatory and destructive disea

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

e processes, according to background information in the study. Rituxamab targets the C

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

20 antigen in certain cells, leading to a reduction in the CD20 cell count. Abatacept in

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

erferes with T-cell activation response, believed to play an important role in rheumatoi

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

arthritis. Tocilizumab targets interleukin-6, which activates many cell populations.

A

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

l three forms of treatment have been found to improve signs of arthritis and symptoms, i

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

prove patients' physical function and health status, and delay progression of joint dama

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

e. All have all been found affective as both stand alone treatments and when used in co

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

junction with alternate remedies. Although still unapproved, intitial trials of rituxim

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

d found that the drug reduced arthritis symptoms by 50 percent for 1/3 of its test group

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.fullofarticles.org.ua/article/231298/fullofarticles-New-Options-For-Rheumatoid-Arthritis.html">New Options For Rheumatoid Arthritis</a>

BB link (for phorums):
[url=http://www.fullofarticles.org.ua/article/231298/fullofarticles-New-Options-For-Rheumatoid-Arthritis.html]New Options For Rheumatoid Arthritis[/url]

Building a website is just the beginning of the journey towards successful e-Business. Once you have a site, it's just like having an additional store in a mega mall called the Internet. Without visitors to your online store, you will not even have a chance to sell your products no matter how great your products are!

A referral always begins with word-of-mouth and the Internet is the perfect breeding ground for word of mouth advertising, also known as viral marketing.

Not a lot of people are familiar with Pheromone, which is quite unfortunate because its ability to drastically improve our sex life is something that can only be described as revolutionary. Join me in my initial brushes with Pheromone, and how I discovered its wondrous and invigorating effects.

Tags

Links

Full of Articles - New Options For Rheumatoid Arthritis

Related Articles: